Dexrazoxane Intravenous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Dexrazoxane Intravenous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Pneumococcal 13-valent conjugate vaccine
- Dexrazoxane Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Dexrazoxane Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Dexrazoxane Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Dexrazoxane Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Dexrazoxane Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Dextenza Insert
- Pms-Sodium Polystyrene Sulfonate-Dextenza intraocular
- Pms-Sodium Polystyrene Sulfonate-Dextran 40
- Pms-Sodium Polystyrene Sulfonate-Dextran 70 6% in 5% Dextrose high molecular weight
- Pms-Sodium Polystyrene Sulfonate-Dextran 75
- Pms-Sodium Polystyrene Sulfonate-Dextran high molecular weight